A new drug, Lucanix, has been found to extend lung
cancer patients lives. Special attention
has been drawn to the extension of life within non-small cell lung cancer – in
this study, the five year survival rate was 50% which is an unheard of success
rate. One researcher quoted in this
article claimed that this vaccine is the most promising lead in life extension
of cancer patients that has occurred within the past couple years. http://news.health.com/2012/04/04/early-study-finds-some-promise-for-lung-cancer-vaccine/
No comments:
Post a Comment